Format

Send to:

Choose Destination
See comment in PubMed Commons below
Nanomedicine. 2013 Jan;9(1):25-7. doi: 10.1016/j.nano.2012.09.001. Epub 2012 Oct 2.

In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds.

Author information

  • 1Department of Radiation Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA 02115, USA. wngwa@lroc.harvard.edu

Abstract

This communication reports the first experimental evidence of gold nanoparticle (AuNP) radiosensitization during continuous low-dose-rate (LDR) gamma irradiation with low-energy brachytherapy sources. HeLa cell cultures incubated with and without AuNP were irradiated with an I-125 seed plaque designed to produce a relatively homogeneous dose distribution in the plane of the cell culture slide. Four sets of irradiation experiments were conducted at low-dose rates ranging from 2.1 to 4.5cGy/h. Residual γH2AX was measured 24h after irradiation and used to compare radiation damage to the cells with and without AuNP. The data demonstrate that the biological effect when irradiating in the presence of 0.2mg/ml concentration of AuNP is about 70%-130% greater than without AuNP. Meanwhile, without radiation, the AuNP showed minimal effect on the cancer cells. These findings provide in vitro evidence that AuNP may be employed as radiosensitizers during continuous LDR brachytherapy.

FROM THE CLINICAL EDITOR:

In this basic science paper, the application of gold nanoparticles as radiosensitizing agents for low dose rate gamma radiation therapy is discussed, demonstrating efficacy in cell culture models.

Copyright © 2013 Elsevier Inc. All rights reserved.

PMID:
23041410
[PubMed - indexed for MEDLINE]
PMCID:
PMC3723694
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk